Aju IB Investment FY 2025 Annual ReportBeta
Aju IB Investment annual report for FY 2025, filed with DART (Korea Financial Supervisory Service) on March 19, 2026. This page provides AI-powered English analysis including business overview, management discussion & analysis (MD&A), risk factors, and KIFRS consolidated financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE).
Aju IB Investment FY 2025 Annual Report Analysis
Business Overview
- • Business model: Venture capital (VC) and private equity (PE) investment with total AUM KRW 2.5T, managing institutional private equity funds (PEF) in FY2025
- • New overseas investment emphasis on US biotech/healthcare with Solasta Ventures established July 2019 and Silicon Valley office opened August 2019
Management Discussion & Analysis
- • Operating revenue KRW 50.7B in 2025, operating profit KRW 11.9B (+29.6% YoY), net income KRW 8.3B (-0.01% YoY)
- • Investment segment drove growth with KRW 188.1B invested in 47 companies, up 16% YoY; reason: proactive investment despite difficult market conditions
Aju IB Investment FY 2025 Key Financial MetricsDART
Total Assets
KRW 338.3B
▼ -1.0% YoY
Operating Cash Flow
-KRW 1.1B
▼ -104.7% YoY
CapEx
KRW 0
▼ -100.0% YoY
Source: KIFRS consolidated financial data from Aju IB Investment annual report on DART. All figures in KRW.
Source: DART (Korea Financial Supervisory Service) · AI summaries generated from the original Korean filing (English output) · Beta: coverage is expanding